insights_auto
Why is PGEN up 2.76%?
Dive Deeperchevron_right
PGEN:NASDAQ
Precigen Inc
$7.81
arrow_upward
+2.76%(+0.21) 1D
$7.81
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$7.60
High
$7.84
Low
$7.48
Mkt. cap
2.80B
Avg. vol.
4.81M
Volume
3.38M
52-wk high
$8.98
52-wk low
$2.99
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
Open
$7.60
High
$7.84
Low
$7.48
Mkt. cap
2.80B
Avg. vol.
4.81M
Volume
3.38M
52-wk high
$8.98
52-wk low
$2.99
EPS
-$1.10
Beta
0.92
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
Insider Monkey
·
37 minutes ago
Dell (DELL) Has Outpaced the S&P 500 by a Wide Stretch. Will the AI-Fueled Run Continue?
The Motley Fool
·
2 hours ago
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
MarketWatch
·
7 hours ago
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com